UFC officials today revealed Belfort was granted a therapeutic-use exemption for testosterone replacement therapy prior to the bout and that his post-fight drug screen “did not indicate the presence of any prohibited substance for increasing performance improvement.”

Belfort and Bisping headlined the Jan. 19 event, which took place at Sao Paulo’s Ibirapuera Gymnasium. The Brazilian scored a second-round TKO over the Brit and then proceeded to call for a rematch with current light heavyweight champion Jon Jones.

All 22 fighters who competed on the card were tested for performance-enhancing drugs and drugs of abuse, and the UFC this past week confirmed one test result in an “irregular” finding, which led to speculation that Belfort – who in 2006 was suspended by the Nevada State Athletic Commission after testing positive for the anabolic steroid 4-Hydroxytestosterone – was the culprit.

“To dispel rumors that have been circulated, Zuffa wishes to clarify that Vitor Belfort’s drug test results were negative and did not indicate the presence of any performance enhancing drugs,” a statement from Zuffa read.

Still, Belfort’s use of testosterone is sure to raise a few eyebrows. However, UFC officials said the fighter has been diagnosed with hypogonadism, the same condition that allowed Chael Sonnen to receive prior exemptions, and that Belfort’s levels have been properly monitored by a Nevada physician.

UFC on FX 7 marked the regulatory debut of the Brazilian MMA Athletic Commission (Comissao Atletica Brasileira de MMA), which is part of the upstart International Mixed Martial Arts Federation. (UFC Vice President of Regulatory Affairs Marc Ratner, whom the Brazilian commission shadowed during the UFC’s three prior events in the country, chairs the IMMAF’s technical committee.)

Belfort, who’s recently dodged questions about his potential use of testosterone-replacement therapy, addressed reporters prior to Saturday’s UFC 156 event in Las Vegas and dismissed the rumors of the failed drug test.

“I think people get jealous when a guy at my age is destroying these people getting title shots,” he said. ” … I think when you look good, the tendency of people to judge you and criticize you is bigger because it sells [newspapers]. See, we’re talking about this, but I had a great performance, and we’re spending more time talking about the controversy than my performance.”

The Latest

Since the early days when the sport was anything but a mainstream endeavor, the MMA industry has thrived and survived through various websites, forums and, perhaps most importantly, social-media platforms.

In this week’s Trading Shots, Danny Downes and Ben Fowlkes look at Ronda Rousey’s 34-second victory over Bethe Correia at UFC 190 and try to put it into terms that capture the moment without getting swept away by it.

A total of 26 fighters got their chance to shine on Saturday as part of UFC 190 at Rio de Janeiro’s HSBC Arena. Now that UFC 190 is in the books, it’s time to commence MMAjunkie’s “Three Stars” ceremony.

The man known for cranking submissions to the point of injury added eye-gouging to his repertoire. But is the controversy of Rousimar Palhares too essential to his bizarre, awful appeal for his employers to take any meaningful action against him?